News

Myelin Repair Foundation's Partner Bionure Announces Positive PreClinical Results for Myelin Repair in Multiple Sclerosis.

03.06.2014

Myelin Repair Foundation's Partner Bionure Announces Positive PreClinical Results for Myelin Repair in Multiple Sclerosis.

By EMILY MULLIN. JUNE 3, 2014.

 

In a preclinical study, Silicon Valley, CA-based Bionure showed that its drug candidate, BN201, promotes myelination--the cellular process of repairing the protective sheath surrounding nerves that is damaged in people with multiple sclerosis.

 

Feature

 

Read more

 

back